Trial Profile
A Single Blind, Randomized, Multiple-period Study In Healthy Adult Volunteers To Investigate The Palatability Of Prototype Age Appropriate Oral Formulations Of Bosutinib For Pediatric Use
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Bosutinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- Sponsors Pfizer
- 21 Jan 2019 Status changed from not yet recruiting to completed.
- 23 Nov 2018 New trial record